Moffitt Cancer Center Clarified Precision Medicine Acquires Molecular Diagnostics Firm Interpares Biomedicine The acquisition brings Interpares' genetic sequencing test, OncoGuardian, into Clarified's portfolio of precision medicine products. Apis Assay Technologies, Moffitt Cancer Center to Evaluate RNA Biomarkers for Cancer Progression The group aims to determine the feasibility of TROLL-2 and TROLL-3 as diagnostic biomarkers for the prediction of treatment efficacy and prognosis in breast cancer. Blood-Based Genetic Risk Score Shows Promise for Prostate Cancer Drug Response, Survival Prediction Premium The team envisions developing an assay to guide targeted treatment for metastatic castration-resistant prostate cancer patients. Foreign Links at Moffitt to Be Investigated The Tampa Bay Times reports that an investigation into foreign ties is being launched following the departure of the CEO, a vice president, and four researchers from the Moffitt Cancer Center. Racial Group Comparison Suggests More Research Needed on Prostate Cancer Recurrence Tests Premium Investigators compared expression in different men across the genes from three commercial panels, arguing that the findings highlight important unknowns. Apr 10, 2019 FDA Warning Letter to Inova Raises Questions About Agency Overreach Into Practice of Medicine Premium Apr 26, 2018 ABRF Speakers Outline Disaster Prep for Core Facilities Sep 29, 2017 With M2Gen Investment, Hearst Seeks to Marry Genomic Cancer Data With Clinical Records Premium Sep 20, 2017 Hearst Invests $75M in M2Gen Mar 27, 2017 International Consortium Links Dozen Loci to Ovarian Cancer Susceptibility Mar 10, 2017 PierianDx Customers Cite 'Creative Partnership' on Clinical Genomics as Key Selling Point Premium Dec 21, 2016 Moffitt Cancer Center Develops Personalized Genomics Approach to Radiation Therapy Sep 12, 2016 HudsonAlpha to Provide Sequencing Services for ORIEN Cancer Initiative Jun 15, 2016 Targeted Colorectal Cancer Sequencing Leads to Potential Prognostic Role for APC Gene Jun 5, 2016 Epigenetic Differences May Explain Lack of Response to Metastatic Melanoma Immunotherapy Sep 8, 2015 Signal Genetics, Moffitt Cancer Center Partner on Multiple Myeloma Research Aug 28, 2015 Moffitt Team Uses Nanostring Tech to ID MiRNA Signature for Early Pancreatic Cancer Detection Premium Aug 11, 2015 Researchers Continue Building Evidence Around Precision Radiation Molecular Tool Premium Aug 4, 2015 Institutional 'Diversity' May Impact Patient Participation in PGx Research, Study Finds Premium May 11, 2015 Moffitt Advancing Preemptive PGx Testing Effort to Optimize Treatment for Patients Receiving Chemo Premium Feb 23, 2015 New Centers Join ORIEN to Uncover Cancer Molecular Data Jan 15, 2015 Proximity Ligation Assays Show Potential to Detect Altered EGFR Signaling, Predict Drug Response Premium Sep 23, 2014 Forma, Moffitt Collaborate on Epigenetics Research Sep 17, 2014 Research Shows Promise of Genomic Testing to Predict Whether Cancer Patients Benefit from Radiation Premium Sep 2, 2014 Rosetta Genomics, Moffitt Cancer Center to Collaborate on microRNA Cancer Diagnostics Load More Breaking News Schott Minifab Acquires Applied Microarrays to Expand US Manufacturing Capabilities Genetic Technologies, WashU Team up to Study Breast Cancer Risk in Woman of African Descent Beckman Coulter, Invitae Partner to Develop NGS Library Prep Applications Sick Infants Profiled with WGS See Better Diagnosis, More Care Changes UC Santa Cruz Center for Live Cell Genomics Wins $13.5M NIH Grant Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development The Scan Highly Similar Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News. Gain of Oversight According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research. Lasker for mRNA Vaccine Work The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.